Home › Niet-kleincellige longkanker › Texas › Tyler
Niet-kleincellige longkanker klinische studies in Tyler, TX
20 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Tyler (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
RekruterenFase 3
- The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0148), Tyler
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #70, Tyler
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 1/2
- Research Site, Tyler
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RekruterenFase 3
- Texas Oncology - Northeast Texas, Tyler
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekruterenFase 3
- Texas Oncology-Northeast Texas, Tyler
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruterenFase 3
- Texas Oncology - Northeast Texas, Tyler
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- The University of Texas Health Science Center at Tyler, Tyler
- Texas Oncology - Northeast, Tyler
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RekruterenFase 3
- The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center, Tyler
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- Texas Oncology - Northeast Texas /ID# 272000, Tyler
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RekruterenFase 3
- Texas Oncology - Northeast Texas, Tyler
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekruterenFase 3
- Clinical Study Site, Tyler
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruterenFase 2/3
- Local Institution - 007-890-A, Tyler
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruterenFase 3
- University of Texas Health Center at Tyler, Tyler
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekruterenFase 1
- Texas Oncology, P.A. - Oncology, Tyler
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- University of Texas at Tyler, Tyler
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
RekruterenFase 1/2
- Texas Oncology - Northeast, Tyler
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- Texas Oncology - Northeast TX, Tyler
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekruterenFase 1/2
- The University of Texas Health Science Center at Tyler, Tyler
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruterenFase 1
- UT Health East Texas HOPE Cancer Center, Tyler
- UT Health East Texas Hope Cancer Center, Tyler
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
RekruterenFase 1
- Texas Oncology - Tyler, Tyler
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Andere studies in Tyler
- Ziekte van Crohn16 studies
- Colitis ulcerosa14 studies
- Colorectale kanker8 studies
- Hartfalen8 studies
- Kanker (alle vormen)7 studies
- Eierstokkanker7 studies
- Endometriumkanker6 studies
- Plaveiselcelcarcinoom van hoofd en hals6 studies
- Borstkanker6 studies
- Metastatische kanker5 studies
- Inflammatoire darmaandoening5 studies
- Chronische lymfatische leukemie5 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.